Table 3.
Gene | Condition (OMIM) | Inheritance | Number of tests performed for each conditiona | |
---|---|---|---|---|
1 | AARS2 | Combined oxidative phosphorylation deficiency 8 | AR | 1 |
2 | AGXT | Primary hyperoxaluria | AR | 2 |
3 | ALDH3A2 | Sjogren-Larsson syndrome | AR | 1 |
4 | ALG12 | Congenital disorder of glycosylation, type Ig | AR | 1 |
5 | AMPD2 | Pontocerebellar hypoplasia, type 9 | AR | 1 |
6 | ANTXR2 | Hyaline fibromatosis syndrome | AR | 2 |
7 | AP3B2 | Developmental and epileptic encephalopathy 48 | AR | 1 |
8 | AP3D1 | Hermansky-Pudlak syndrome 10 | AR | 1 |
9 | ARSA | Metachromatic leukodystrophy | AR | 3 |
10 | ASL | Argininosuccinic aciduria | AR | 1 |
11 | ASPA | Canavan disease | AR | 1 |
12 | ATP8A2 | Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4 | AR | 1 |
13 | B3GALNT2 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11) | AR | 1 |
14 | CPS1 | Carbamoylphosphate synthetase I deficiency | AR | 2 |
15 | CTSA | Galactosialidosis | AR | 3 |
16 | DGUOK | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | AR | 2 |
17 | DLAT | Pyruvate dehydrogenase E2 deficiency | AR | 1 |
18 | DMD | Duchenne muscular dystrophy | XL | 1 |
19 | EIF2AK3 | Wolcott-Rallison syndrome | AR | 1 |
20 | EMC1 | Cerebellar atrophy, visual impairment, and psychomotor retardation | AR | 1 |
21 | ERCC5 | Xeroderma pigmentosum, group G/Cockayne syndrome | AR | 2 |
22 | ETFDH | Glutaric acidemia II | AR | 3 |
23 | FBXL4 | Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type) | AR | 2 |
24 | FGFR3 | Thanatophoric dysplasia, type II | AD | 2 |
25 | FKTN | Muscular dystrophy-dystroglycanopathy (congenital without mental retardation) type 4B | AR | 1 |
26 | FRAS1 | Fraser syndrome | AR | 1 |
27 | GALC | Krabbe disease | AR | 1 |
28 | GAN | Giant axonal neuropathy | AR | 1 |
29 | GLB1 | GM1-gangliosidosis, type I | AR | 1 |
30 | HBB | Beta thalassemia | AR | 2 |
31 | HSD17B4 | Perrault syndrome 1 | AR | 1 |
32 | IBA57 | Multiple mitochondrial dysfunctions syndrome 3 | AR | 1 |
33 | IDUA | Mucopolysaccharidosis type I (Hurler) | AR | 1 |
34 | IFT172 | Short-rib thoracic dysplasia 10 with or without polydactyly | AR | 1 |
35 | ITGA8 | Renal hypoplasia/aplasia 1 | AR | 1 |
36 | LAMA3 | Epidermolysis bullosa, junctional, Herlitz type | AR | 1 |
37 | MPV17 | Mitochondrial DNA depletion syndrome type 6 | AR | 1 |
38 | NAGLU | Mucopolysaccharidosis type IIIB (Sanfilippo B) | AR | 1 |
39 | NFASC | Neurodevelopmental disorder with central and peripheral motor dysfunction | AR | 1 |
40 | OSTM1 | Osteopetrosis | AR | 2 |
41 | PC | Pyruvate carboxylase deficiency | AR | 1 |
42 | PCCB | Propionic acidemia | AR | 1 |
43 | PEX1 | Peroxisome biogenesis disorder 1A (Zellweger) | AR | 7 |
44 | PEX14 | Peroxisome biogenesis disorder 13A (Zellweger) | AR | 1 |
45 | PEX26 | Peroxisome biogenesis disorder 7A (Zellweger) | AR | 2 |
46 | PGAP3 | Hyperphosphatasia with mental retardation syndrome 4 | AR | 1 |
47 | PKHD1 | Polycystic kidney disease 4, with or without hepatic disease | AR | 1 |
48 | PLA2G6 | Neurodegeneration with brain iron accumulation 2B | AR | 1 |
49 | PRUNE1 | Prune-1 syndrome | AR | 3 |
50 | RAB3GAP1 | Warburg-Micro syndrome | AR | 2 |
51 | RARS | Hypomyelinating leukodystrophy type 9 | AR | 1 |
52 | RARS2 | Pontocerebellar hypoplasia, type 6 | AR | 1 |
53 | RECQL4 | RAPADILINO syndrome | AR | 1 |
54 | SMN1 | Spinal muscular atrophy-1 | AR | 17 |
55 | SPINK5 | Netherton syndrome | AR | 1 |
56 | STT3A | Congenital disorder of glycosylation, type Iw | AR | 2 |
57 | SUOX | Sulfite oxidase deficiency | AR | 3 |
58 | TBCE | Hypoparathyroidism-retardation-dysmorphism syndrome | AR | 3 |
59 | TINF2 | Dyskeratosis congenita | AD | 1 |
60 | TMEM138 | Joubert syndrome 16 | AR | 1 |
61 | TRIP11 | Achondrogenesis, type IA | AR | 1 |
62 | TRNT1 | Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay | AR | 1 |
63 | UGT1A1 | Crigler-Najjar syndrome, type I | AR | 1 |
64 | VPS33B | Arthrogryposis, renal dysfunction, and cholestasis 1 | AR | 5 |
aData includes repeat procedures. Individual TOP outcomes were not recorded to maintain the privacy of the families’ decisions. AR, autosomal recessive; AD, autosomal dominant; XL, X-linked